Filter
717
Text search:
medicines
and
related
substances
Featured
Recommendations
92
New Publications
192
Language
Document type
No document type
370
Guidelines
144
Studies & Reports
87
Manuals
59
Strategic & Response Plan
25
Training Material
17
Situation Updates
6
Resource Platforms
3
Fact sheets
3
Brochures
2
Infographics
1
Countries / Regions
South Africa
40
India
39
Kenya
32
Western and Central Europe
22
Zambia
18
Nigeria
17
Ethiopia
17
Global
17
Uganda
16
Ghana
15
Sierra Leone
12
Nepal
11
Tanzania
11
Namibia
10
Eswatini/ Swaziland
9
Liberia
8
Zimbabwe
8
Indonesia
8
Ukraine
8
Myanmar / Burma
8
Botswana
7
Africa
7
Syria
6
Rwanda
6
Philippines
5
Bangladesh
5
Malawi
5
Eastern Europe
5
Pakistan
4
Cambodia
4
North Macedonia
4
South–East Asia Region
4
Latin America and the Carribbean
4
Lesotho
3
Eastern Europe and Central Asia
3
Moldova
3
Afghanistan
2
Germany
2
Thailand
2
Hungary
2
Sri Lanka
2
Bhutan
2
Poland
2
Tajikistan
2
Kyrgyzstan
2
Georgia
2
Burkina Faso
1
Senegal
1
Congo, Democratic Republic of
1
Morocco
1
Cameroon
1
Haiti
1
Iraq
1
Jordan
1
Lebanon
1
Mozambique
1
Sudan
1
Argentina
1
Brazil
1
Switzerland
1
Serbia
1
Colombia
1
Libya
1
Mexico
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Southern Africa
1
Russia
1
Iran
1
Kazakhstan
1
Jamaica
1
Maldives
1
Mauritius
1
United Kingdom
1
Norway
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
301
Clinical Guidelines
52
Public Health
29
Women & Child Health
23
Pharmacy & Technologies
17
Capacity Building
16
Key Resources
13
Protection & Security
1
Toolboxes
Mental Health
91
Pharmacy
85
AMR
66
HIV
43
TB
25
COVID-19
24
Caregiver
23
Planetary Health
17
Conflict
15
Rapid Response
15
NCDs
15
Ebola
11
Specific Hazards
7
Global Health Education
6
Refugee
5
Natural Hazards
3
Zika
2
NTDs
2
Health Financing Toolbox
2
Disability
1
Cholera
1
Polio
1
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (
...
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority
...
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenz
...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal
...
This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though TB-focused
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to t
...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in
...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals
...
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria,
...
This module covers common Non-Communicable Diseases such as Hypertension, Diabetes and three common cancers (Cervical,
Breast and Oral cancer). The focus of this module is on building the knowledge
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, bo
...
Statutory Instrument 150 of 1991 | S.I. 150 of 1991 | Amended by S.I.’ s 298/93, 61/94, 319/94, 199/98, 256/98, 36/99, 24/2001 and 257/2002, 105 and 222 /2004